Related references
Note: Only part of the references are listed.American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
Karlyn A. Martin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis
Ella Grilz et al.
EUROPEAN HEART JOURNAL (2021)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evidence of impaired dabigatran absorption following laparoscopic Roux-en-Y gastric bypass surgery: the Auckland regional experience (2011-2018)
Brian Grainger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology
Gordon Chu et al.
BLOOD REVIEWS (2019)
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Wonkyung Byon et al.
CLINICAL PHARMACOKINETICS (2019)
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH
Aurelien Delluc et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
How to proceed with long-term anticoagulation in patient after total gastrectomy and atrial fibrillation?
Tomas Bolek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Cancer-associated thrombosis: the when, how and why
Caio J. Fernandes et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
J. Douxfils et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Robert C. Gosselin et al.
THROMBOSIS AND HAEMOSTASIS (2018)
The effect of bariatric surgery on direct-acting oral anticoagulant drug levels
Amihai Rottenstreich et al.
THROMBOSIS RESEARCH (2018)
The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study
Dino Kroell et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Norbaini Binti Abdol Razak et al.
CANCERS (2018)
Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
Hakeam A. Hakeam et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
The principles of the surgical management of gastric cancer
Elroy P. Weledji
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY (2017)
Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance
Karlyn A. Martin et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Evaluation of regional gastrointestinal absorption of edoxaban using the enterion capsule
Dolly A. Parasrampuria et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
Paul A. Reilly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Pharmacokinetics of rivaroxaban after bariatric surgery: a case report
Adrian Mahlmann et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin
Wolfgang G. Eisert et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Share Paper
